Howard Fillit
Howard Fillit, MD, is the co-founder and chief science officer of the Alzheimer’s Drug Discovery Foundation in New York. He is an influential figure in Alzheimer's research, advocating for the advancement of treatments and prevention strategies for the disease. Fillit was recently mentioned in the news for commenting on a study that suggests early treatment with anti-amyloid medications could delay Alzheimer's onset, highlighting a shift towards prevention in Alzheimer's research.
Not in the pool (under ¢1).
Recent news mentions
Dr. Howard Fillit, co-founder and chief science officer at the Alzheimer’s Drug Discovery Foundation, said that the ability to diagnose Alzheimer’s earlier with a simple blood test is a game changer.
FDA greenlights first blood test to help diagnose Alzheimer’s disease in the US
United States· 2025-05-18
Howard Fillit, MD, co-founder and chief science officer at the Alzheimer’s Drug Discovery Foundation in New York, noted that the study shows for the first time that early treatment can delay the onset of Alzheimer’s.
Experimental drug could help prevent Alzheimer's in certain population: studyUnited States· 2025-03-22
